{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T17:40:52Z","timestamp":1793814052641,"version":"4.6.1"},"reference-count":73,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"published-print":{"date-parts":[[2022,3,1]]},"DOI":"10.1001\/jamapediatrics.2021.4606","type":"journal-article","created":{"date-parts":[[2021,12,6]],"date-time":"2021-12-06T16:02:26Z","timestamp":1638806546000},"page":"304","source":"Crossref","is-referenced-by-count":60,"title":["<scp>A<\/scp>ccess to Medications for Opioid Use Disorder and Associated Factors Among Adolescents and Young Adults"],"prefix":"10.1001","volume":"176","author":[{"given":"Andreas","family":"Pilarinos","sequence":"first","affiliation":[{"name":"British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada"},{"name":"Interdisciplinary Studies Graduate Program, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Bromberg","sequence":"additional","affiliation":[{"name":"Yale School of Public Health, Yale University, Laboratory of Epidemiology and Public Health, New Haven, Connecticut"},{"name":"Centre for Interdisciplinary Research on AIDS, New Haven, Connecticut"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Karamouzian","sequence":"additional","affiliation":[{"name":"British Columbia Centre on Substance Use, Vancouver, British Columbia, Canada"},{"name":"School of Population and Public Health, University of British Columbia, Vancouver, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"prv210008r1","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1007\/s40429-018-0228-5","article-title":"The deepening opioid crisis in North America: historical context and current solutions.","volume":"5","author":"Donroe","year":"2018","journal-title":"Curr Addict Rep."},{"issue":"6","key":"prv210008r2","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1001\/jama.2018.6566","article-title":"Increasing fatality rates from preventable deaths in teenagers and young adults.","volume":"320","author":"Lee","year":"2018","journal-title":"JAMA"},{"issue":"9","key":"prv210008r3","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1111\/add.v114.9","article-title":"Modelling the combined impact of interventions in averting deaths during a synthetic-opioid overdose epidemic.","volume":"114","author":"Irvine","year":"2019","journal-title":"Addiction"},{"key":"prv210008r4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.jsat.2018.07.008","article-title":"Comparison between buprenorphine provider availability and opioid deaths among US counties.","volume":"93","author":"Jones","year":"2018","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"prv210008r5","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1542\/pir.2017-0153","article-title":"Medication treatment of adolescent opioid use disorder in primary care.","volume":"39","author":"Carney","year":"2018","journal-title":"Pediatr Rev"},{"issue":"4","key":"prv210008r6","doi-asserted-by":"publisher","first-page":"393","DOI":"10.15288\/jsad.2019.80.393","article-title":"Medications for maintenance treatment of opioid use disorder in adolescents: a narrative review and assessment of clinical benefits and potential risks.","volume":"80","author":"Camenga","year":"2019","journal-title":"J Stud Alcohol Drugs"},{"issue":"1","key":"prv210008r7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1093\/epirev\/mxaa001","article-title":"Adherence to and retention in medications for opioid use disorder among adolescents and young adults.","volume":"42","author":"Viera","year":"2020","journal-title":"Epidemiol Rev"},{"issue":"8","key":"prv210008r8","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1001\/jamapediatrics.2017.1269","article-title":"Closing the medication-assisted treatment gap for youth with opioid use disorder.","volume":"171","author":"Saloner","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"2","key":"prv210008r9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/00952990.2017.1399403","article-title":"Medication-assisted treatment for youth with opioid use disorder: current dilemmas and remaining questions.","volume":"44","author":"Chang","year":"2018","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"4","key":"prv210008r10","doi-asserted-by":"publisher","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"issue":"5","key":"prv210008r11","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/add.1992.87.issue-5","article-title":"Who should receive methadone maintenance?","volume":"87","author":"Bell","year":"1992","journal-title":"Br J Addict"},{"key":"prv210008r12","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108404","article-title":"The cascade of care for opioid use disorder among youth in British Columbia, 2018.","volume":"130","author":"Krebs","year":"2021","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"prv210008r13","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.jadohealth.2020.03.005","article-title":"Adolescent-serving addiction treatment facilities in the United States and the availability of medications for opioid use disorders.","volume":"67","author":"Alinsky","year":"2020","journal-title":"J Adolesc Health"},{"issue":"3","key":"prv210008r14","doi-asserted-by":"publisher","first-page":"e125","DOI":"10.1016\/j.amepre.2020.03.022","article-title":"Opioid use disorder treatment facilities with programs for special populations.","volume":"59","author":"Hadland","year":"2020","journal-title":"Am J Prev Med"},{"issue":"4","key":"prv210008r15","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1080\/08897077.2014.960959","article-title":"Organizational predictors and use of evidence-based practices in adolescent substance abuse treatment.","volume":"36","author":"Paino","year":"2015","journal-title":"Subst Abus"},{"issue":"3","key":"prv210008r16","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2019.5183","article-title":"Receipt of addiction treatment after opioid overdose among Medicaid-enrolled adolescents and young adults.","volume":"174","author":"Alinsky","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"6","key":"prv210008r17","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.whi.2016.09.002","article-title":"A moral or medical problem? the relationship between legal penalties and treatment practices for opioid use disorders in pregnant women.","volume":"26","author":"Angelotta","year":"2016","journal-title":"Womens Health Issues"},{"issue":"12","key":"prv210008r18","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1097\/MLR.0000000000000803","article-title":"Medicaid coverage of methadone maintenance and the use of opioid agonist therapy among pregnant women in specialty treatment.","volume":"55","author":"Bachhuber","year":"2017","journal-title":"Med Care"},{"issue":"1","key":"prv210008r19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jadohealth.2020.01.016","article-title":"Medication treatment and health care use among adolescents with opioid use disorder in Ohio.","volume":"67","author":"Chavez","year":"2020","journal-title":"J Adolesc Health"},{"issue":"14","key":"prv210008r20","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.3109\/10826080802494800","article-title":"Methadone maintenance treatment for youth: experiences of clients, staff, and parents.","volume":"44","author":"Guarino","year":"2009","journal-title":"Subst Use Misuse"},{"issue":"8","key":"prv210008r21","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/jamapediatrics.2017.0745","article-title":"Trends in receipt of buprenorphine and naltrexone for opioid use disorder among adolescents and young adults, 2001-2014.","volume":"171","author":"Hadland","year":"2017","journal-title":"JAMA Pediatr"},{"issue":"2","key":"prv210008r22","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.jadohealth.2017.11.033","article-title":"Use of evidence-based medication treatment among Medicaid-enrolled youth with opioid use disorder, 2014-2015.","volume":"62","author":"Hadland","year":"2018","journal-title":"J Adolesc Health."},{"issue":"11","key":"prv210008r23","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1001\/jamapediatrics.2018.2143","article-title":"Receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder.","volume":"172","author":"Hadland","year":"2018","journal-title":"JAMA Pediatr"},{"key":"prv210008r24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.jsat.2017.01.011","article-title":"Substance use, treatment, and demographic characteristics of pregnant women entering treatment for opioid use disorder differ by United States census region.","volume":"76","author":"Hand","year":"2017","journal-title":"J Subst Abuse Treat"},{"issue":"4","key":"prv210008r25","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1080\/08897077.2016.1146649","article-title":"Factors associated with buprenorphine versus methadone use in pregnancy.","volume":"37","author":"Krans","year":"2016","journal-title":"Subst Abus"},{"issue":"5","key":"prv210008r26","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1097\/AOG.0000000000003231","article-title":"Medication-assisted treatment use among pregnant women with opioid use disorder.","volume":"133","author":"Krans","year":"2019","journal-title":"Obstet Gynecol"},{"issue":"1","key":"prv210008r27","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s13011-016-0082-1","article-title":"Access to substance use treatment among young adults who use prescription opioids non-medically.","volume":"11","author":"Liebling","year":"2016","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"4","key":"prv210008r28","first-page":"394","article-title":"Substance use characteristics and treatment perceptions among opioid dependent pregnant women initiating methadone treatment.","volume":"21","author":"Quigley","year":"2012","journal-title":"Am J Addict"},{"issue":"6","key":"prv210008r29","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/j.jadohealth.2016.12.023","article-title":"Medication-assisted treatment for adolescents in specialty treatment for opioid use disorder.","volume":"60","author":"Feder","year":"2017","journal-title":"J Adolesc Health"},{"issue":"1","key":"prv210008r30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.annemergmed.2019.07.030","article-title":"Characteristics and receipt of medication treatment among young adults who experience a nonfatal opioid-related overdose.","volume":"75","author":"Bagley","year":"2020","journal-title":"Ann Emerg Med"},{"issue":"2 Suppl","key":"prv210008r31","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1016\/j.jadohealth.2020.12.095","article-title":"Characteristics of youth receiving medication treatment for opioid use disorder.","volume":"68","author":"Bell","year":"2021","journal-title":"J Adolesc Health"},{"key":"prv210008r32","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108159","article-title":"Medications for opioid use disorder in pregnancy in a state women\u2019s prison facility.","volume":"214","author":"Knittel","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"8","key":"prv210008r33","doi-asserted-by":"publisher","first-page":"e2013456","DOI":"10.1001\/jamanetworkopen.2020.13456","article-title":"Association of pregnancy and insurance status with treatment access for opioid use disorder.","volume":"3","author":"Patrick","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"prv210008r34","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.5734","article-title":"Assessment of racial and ethnic disparities in the use of medication to treat opioid use disorder among pregnant women in Massachusetts.","volume":"3","author":"Schiff","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"prv210008r35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003119","article-title":"Medications for opioid use disorder among pregnant women referred by criminal justice agencies before and after Medicaid expansion: a retrospective study of admissions to treatment centers in the United States.","volume":"17","author":"Winkelman","year":"2020","journal-title":"PLoS Med"},{"issue":"3","key":"prv210008r36","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1080\/10550887.2012.694603","article-title":"Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in New York City: the need to expand access to buprenorphine\/naloxone in marginalized populations.","volume":"31","author":"Stancliff","year":"2012","journal-title":"J Addict Dis"},{"issue":"1","key":"prv210008r37","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12954-017-0159-9","article-title":"Social-structural factors influencing periods of injection cessation among marginalized youth who inject drugs in Vancouver, Canada: an ethno-epidemiological study.","volume":"14","author":"Boyd","year":"2017","journal-title":"Harm Reduct J"},{"issue":"5","key":"prv210008r38","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1080\/16066350500150624","article-title":"Heroin use and barriers to treatment in street-involved youth.","volume":"13","author":"Brands","year":"2005","journal-title":"Addict Res Theory"},{"issue":"6","key":"prv210008r39","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1111\/dar.2011.30.issue-6","article-title":"The Cedar Project: methadone maintenance treatment among young Aboriginal people who use opioids in two Canadian cities.","volume":"30","author":"Yang","year":"2011","journal-title":"Drug Alcohol Rev"},{"issue":"3","key":"prv210008r40","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1111\/dar.2017.36.issue-3","article-title":"A qualitative study of reasons for seeking and ceasing opioid substitution treatment in prisons in New South Wales, Australia.","volume":"36","author":"Larney","year":"2017","journal-title":"Drug Alcohol Rev"},{"issue":"1","key":"prv210008r41","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jsat.2004.05.001","article-title":"Young people with heroin dependence: findings from the Australian Treatment Outcome Study (ATOS).","volume":"27","author":"Mills","year":"2004","journal-title":"J Subst Abuse Treat"},{"key":"prv210008r42","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1747-597X-9-44","article-title":"Enhancing motivation within a rapid opioid substitution treatment feasibility RCT: a nested qualitative study.","volume":"9","author":"Ayres","year":"2014","journal-title":"Subst Abuse Treat Prev Policy"},{"issue":"2","key":"prv210008r43","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/camh.2014.19.issue-2","article-title":"Psychopharmacological treatment of young people with substance dependence: a survey of prescribing practices in England.","volume":"19","author":"Bateman","year":"2014","journal-title":"Child Adolesc Ment Health"},{"issue":"2","key":"prv210008r44","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1017\/S0790966700010934","article-title":"Opiate-dependent adolescents in Ireland: a descriptive study at treatment entry.","volume":"25","author":"Fagan","year":"2008","journal-title":"Ir J Psychol Med"},{"issue":"1","key":"prv210008r45","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jsat.2011.07.007","article-title":"Outcome of heroin-dependent adolescents presenting for opiate substitution treatment.","volume":"42","author":"Smyth","year":"2012","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"prv210008r46","first-page":"33","article-title":"Prescription opioids (substitution medications and pain medications) in patients looking for opioid agonist treatment in northern and southern Italy, using a 18-month survey methodology.","volume":"17","author":"Maremmani","year":"2015","journal-title":"Heroin Addict Relat Clin Probl"},{"issue":"6","key":"prv210008r47","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3109\/00952990903374080","article-title":"Characteristics of opioid-using pregnant women who accept or refuse participation in a clinical trial: screening results from the MOTHER study.","volume":"35","author":"Stine","year":"2009","journal-title":"Am J Drug Alcohol Abuse"},{"issue":"5","key":"prv210008r48","first-page":"45","article-title":"Effects of non-scheduled urine drug tests among all students at a private high school in the USA.","volume":"19","author":"Adelson","year":"2017","journal-title":"Heroin Addict Relat Clin Probl."},{"issue":"2","key":"prv210008r49","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/ajad.v29.2","article-title":"Predictors of medication utilization for opioid use disorder among Medicaid-insured HIV patients in New York.","volume":"29","author":"Choi","year":"2020","journal-title":"Am J Addict"},{"issue":"1-3","key":"prv210008r50","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.drugalcdep.2011.10.016","article-title":"The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: recent service utilization trends in the use of buprenorphine and methadone.","volume":"123","author":"Stein","year":"2012","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"prv210008r51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0226349","article-title":"Differences in receipt of opioid agonist treatment and time to enter treatment for opioid use disorder among specialty addiction programs in the United States, 2014-17.","volume":"14","author":"Yang","year":"2019","journal-title":"PLoS One"},{"key":"prv210008r53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2017.04.005","article-title":"Why aren\u2019t physicians prescribing more buprenorphine?","volume":"78","author":"Huhn","year":"2017","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"prv210008r54","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jsat.2008.06.006","article-title":"Factors affecting willingness to provide buprenorphine treatment.","volume":"36","author":"Netherland","year":"2009","journal-title":"J Subst Abuse Treat"},{"issue":"8","key":"prv210008r55","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1001\/jamapediatrics.2020.1033","article-title":"Racial\/ethnic bias in pediatric care and the criminalization of poverty and race\/ethnicity\u2014seek and ye shall find.","volume":"174","author":"Dreyer","year":"2020","journal-title":"JAMA Pediatr"},{"issue":"1","key":"prv210008r56","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/1747-597X-9-34","article-title":"Cultural interventions to treat addictions in Indigenous populations: findings from a scoping study.","volume":"9","author":"Rowan","year":"2014","journal-title":"Subst Abuse Treat Prev Policy"},{"key":"prv210008r57","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.evalprogplan.2017.10.005","article-title":"Response to culturally competent drug treatment among homeless persons with different living arrangements.","volume":"66","author":"Guerrero","year":"2018","journal-title":"Eval Program Plann"},{"issue":"12","key":"prv210008r58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225548","article-title":"Assessing service and treatment needs and barriers of youth who use illicit and non-medical prescription drugs in northern Ontario, Canada.","volume":"14","author":"Russell","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"prv210008r59","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1111\/add.v112.5","article-title":"Making the hard work of recovery more attractive for those with substance use disorders.","volume":"112","author":"McKay","year":"2017","journal-title":"Addiction"},{"issue":"3","key":"prv210008r60","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1893","article-title":"Medication-assisted treatment of adolescents with opioid use disorders.","volume":"138","author":"Committee on Substance Use and Prevention","year":"2016","journal-title":"Pediatrics"},{"issue":"6","key":"prv210008r61","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1007\/s10461-012-0373-0","article-title":"Peer-education intervention to reduce injection risk behaviors benefits high-risk young injection drug users: a latent transition analysis of the CIDUS 3\/DUIT study.","volume":"17","author":"Mackesy-Amiti","year":"2013","journal-title":"AIDS Behav"},{"issue":"4","key":"prv210008r63","doi-asserted-by":"publisher","first-page":"292","DOI":"10.2174\/1874473711104040292","article-title":"Drug-related death following release from prison: a brief review of the literature with recommendations for practice.","volume":"4","author":"Leach","year":"2011","journal-title":"Curr Drug Abuse Rev"},{"issue":"2","key":"prv210008r64","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1056\/NEJMsa064115","article-title":"Release from prison\u2014a high risk of death for former inmates.","volume":"356","author":"Binswanger","year":"2007","journal-title":"N Engl J Med"},{"issue":"9","key":"prv210008r65","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1016\/S1701-2163(16)34659-X","article-title":"An evaluation of rooming-in among substance-exposed newborns in British Columbia.","volume":"32","author":"Abrahams","year":"2010","journal-title":"J Obstet Gynaecol Can"},{"issue":"4","key":"prv210008r66","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1177\/0272431698018004001","article-title":"Early adolescent street youth: an overlooked population with unique problems and service needs.","volume":"18","author":"Unger","year":"1998","journal-title":"J Early Adolesc"},{"issue":"4","key":"prv210008r67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/CXA.0000000000000032","article-title":"Youth require tailored treatment for opioid use and mental health problems: a comparison with adults.","volume":"9","author":"Corace","year":"2018","journal-title":"Can J Addict"},{"key":"prv210008r68","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.drugalcdep.2017.04.032","article-title":"Young people who use drugs engaged in harm reduction programs in New York City: overdose and other risks.","volume":"178","author":"Calvo","year":"2017","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"prv210008r69","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s40263-020-00711-x","article-title":"Pharmacological treatment of methamphetamine\/amphetamine dependence: a systematic review.","volume":"34","author":"Siefried","year":"2020","journal-title":"CNS Drugs"},{"issue":"7","key":"prv210008r70","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1111\/dar.v39.7","article-title":"Self-managing illicit stimulant use: a qualitative study with patients receiving injectable opioid agonist treatment.","volume":"39","author":"Palis","year":"2020","journal-title":"Drug Alcohol Rev"},{"issue":"10034","key":"prv210008r71","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.1016\/S0140-6736(16)00205-1","article-title":"Sustained-release dexamfetamine in the treatment of chronic cocaine-dependent patients on heroin-assisted treatment: a randomised, double-blind, placebo-controlled trial.","volume":"387","author":"Nuijten","year":"2016","journal-title":"Lancet"},{"issue":"2","key":"prv210008r72","doi-asserted-by":"publisher","first-page":"e2036512","DOI":"10.1001\/jamanetworkopen.2020.36512","article-title":"Prevalence and co-occurrence of alcohol, nicotine, and other substance use disorder diagnoses among US transgender and cisgender adults.","volume":"4","author":"Hughto","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"4","key":"prv210008r73","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1111\/j.1360-0443.2008.02149.x","article-title":"Sexual orientation and adolescent substance use: a meta-analysis and methodological review.","volume":"103","author":"Marshal","year":"2008","journal-title":"Addiction"},{"key":"prv210008r52","first-page":"145","volume-title":"Adolescent Substance Abuse: Psychiatric Comorbidity and High-Risk Behaviors","author":"Upadhyaya","year":"2008"},{"key":"prv210008r62","volume-title":"Global State of Harm Reduction","author":"Harm Reduction International","year":"2020"}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2786339\/jamapediatrics_pilarinos_2021_rv_210008_1646329665.63047.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T16:12:17Z","timestamp":1646669537000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2786339"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2022,3,1]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2021.4606","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,1]]}}}